WallStreetZenWallStreetZen

NASDAQ: HSCS
Heart Test Laboratories Inc Stock

$0.12+0.00 (+0%)
Updated Feb 21, 2024
HSCS Price
$0.12
Fair Value Price
$0.01
Market Cap
$7.63M
52 Week Low
$0.11
52 Week High
$1.75
P/E
-0.2x
P/B
-4.63x
P/S
465.98x
PEG
N/A
Dividend Yield
N/A
Revenue
$5.85k
Earnings
-$6.09M
Gross Margin
61%
Operating Margin
-99,286.31%
Profit Margin
-104,097.6%
Debt to Equity
-2.44
Operating Cash Flow
-$5M
Beta
-0.08
Next Earnings
Mar 14, 2024
Ex-Dividend
N/A
Next Dividend
N/A

HSCS Overview

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HSCS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HSCS ($0.12) is overvalued by 966.45% relative to our estimate of its Fair Value price of $0.01 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HSCS ($0.12) is not significantly undervalued (966.45%) relative to our estimate of its Fair Value price of $0.01 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HSCS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HSCS due diligence checks available for Premium users.

Be the first to know about important HSCS news, forecast changes, insider trades & much more!

HSCS News

Valuation

HSCS fair value

Fair Value of HSCS stock based on Discounted Cash Flow (DCF)
Price
$0.12
Fair Value
$0.01
Overvalued by
966.45%
HSCS ($0.12) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HSCS ($0.12) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HSCS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HSCS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.2x
Industry
36.28x
Market
28.8x

HSCS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-4.63x
Industry
4.02x

HSCS's financial health

Profit margin

Revenue
$3.9k
Net Income
-$1.7M
Profit Margin
-44,830.2%
HSCS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HSCS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.4M
Liabilities
$4.0M
Debt to equity
-2.44
HSCS's short-term liabilities ($3.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HSCS's short-term assets ($1.81M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HSCS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HSCS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.0M
Investing
-$2.0k
Financing
$514.6k
HSCS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HSCS vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
HSCS$7.63M-0.83%-0.20x-4.63x
OSA$8.04M-24.03%-0.35x-0.24x
VERO$6.75M+2.18%-0.18x-0.52x
INBS$8.68M-4.72%-0.04x2.65x
AFIB$6.42M-8.75%-0.20x0.20x

Heart Test Laboratories Stock FAQ

What is Heart Test Laboratories's quote symbol?

(NASDAQ: HSCS) Heart Test Laboratories trades on the NASDAQ under the ticker symbol HSCS. Heart Test Laboratories stock quotes can also be displayed as NASDAQ: HSCS.

If you're new to stock investing, here's how to buy Heart Test Laboratories stock.

What is the 52 week high and low for Heart Test Laboratories (NASDAQ: HSCS)?

(NASDAQ: HSCS) Heart Test Laboratories's 52-week high was $1.75, and its 52-week low was $0.11. It is currently -93.14% from its 52-week high and 8.11% from its 52-week low.

How much is Heart Test Laboratories stock worth today?

(NASDAQ: HSCS) Heart Test Laboratories currently has 63,611,630 outstanding shares. With Heart Test Laboratories stock trading at $0.12 per share, the total value of Heart Test Laboratories stock (market capitalization) is $7.63M.

Heart Test Laboratories stock was originally listed at a price of $1.70 in Jun 15, 2022. If you had invested in Heart Test Laboratories stock at $1.70, your return over the last 1 years would have been -92.94%, for an annualized return of -92.94% (not including any dividends or dividend reinvestments).

How much is Heart Test Laboratories's stock price per share?

(NASDAQ: HSCS) Heart Test Laboratories stock price per share is $0.12 today (as of Feb 21, 2024).

What is Heart Test Laboratories's Market Cap?

(NASDAQ: HSCS) Heart Test Laboratories's market cap is $7.63M, as of Feb 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Heart Test Laboratories's market cap is calculated by multiplying HSCS's current stock price of $0.12 by HSCS's total outstanding shares of 63,611,630.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.